Directly Acting Oral Anticoagulants for the Prevention of Stroke in Atrial Fibrillation in England and Wales: Cost-Effectiveness Model and Value of Information Analysis

Objectives. Determine the optimal, licensed, first-line anticoagulant for prevention of ischemic stroke in patients with non-valvular atrial fibrillation (AF) in England and Wales from the UK National Health Service (NHS) perspective and estimate value to decision making of further research. Methods...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:MDM Policy Pract
Main Authors: Thom, Howard H. Z., Hollingworth, Will, Sofat, Reecha, Wang, Zhenru, Fang, Wei, Bodalia, Pritesh N., Bryden, Peter A., Davies, Philippa A., Caldwell, Deborah M., Dias, Sofia, Eaton, Diane, Higgins, Julian P. T., Hingorani, Aroon D., Lopez-Lopez, Jose A., Okoli, George N., Richards, Alison, Salisbury, Chris, Savović, Jelena, Stephens-Boal, Annya, Sterne, Jonathan A. C., Welton, Nicky J.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6699015/
https://ncbi.nlm.nih.gov/pubmed/31453363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2381468319866828
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados